Advances in science have entailed upon the human race the windfall
of increased life expectancy. While the average life span in developed
countries have registered an increase of 20 years and pegged at 82 yrs, in
India it is 66.4yrs. Long life is a remarkable achievement and society yearns
for the same. But long life also puts a burgeoning pressure on the resources
and opportunities in developing countries. The real challenge that embodies long
life is living better. Hence the real task accompanying the bantam feat is to ensure
that an individual should age gracefully, physically fit, mentally sharp and
economically secure.
Extraordinary medical
and scientific advances have contributed enormously towards improving the quality
of living and subsequently the life expectancy surged. The phenomenon
described as technophysio-evolution described by eminent economist Robert Fogel
has brought about immense biological changes in the physiology of the human
body which was made possible through numerous advances in technology. A steady
supply of food grains, discovery of electricity, invention of techniques like
refrigeration, pasteurisation, water purification, vaccination has dramatically
reduced deaths due to contagious diseases and premature deaths. These changes have
brought an increase in body size by over 50 % and improved robustness and
capacity of vital organs too. Even our brains have begun to process information
much faster. With the availability of technologically advanced devices ageing
has been reduced to minor inconvenience.
Scientists have been relentlessly toiling for several decades
to crack the code of ageing. Research carried out at the University of Texas Health
Science Centre San Antonio, indicated that a mouse fed with rapamycin seemed to
age slowly by reducing damage to certain cells. Even the vital organs like
heart and liver fed with rapamycin aged very slowly and its nervous system was
quite agile and extremely receptive when compared to its peers of the same age.
It was devoid of tumours even. Rafamycin diet laced mouse lived 20% longer than
unfed ones. Rapamycin is administered to human subjects to prevent organ
rejection after transplantation. Rapamycin was obtained from soil samples in
1964 in an expedition to Easter Island. It works on a wide variety of species
like yeast, flies, mice and worms and hence convenient for extensive studies.
Rapamycin works by interrupting with the functioning of a
gene mTOR, found in mouse and man. mTOR controls the intake of cells and use of
energy. It signals cells to absorb more nutrients when food is abundant and
taps into other energy related pathways when nutrients are no longer available.
It restricts intake of calories and prolongs life. Rapamycin suffers from
pit falls too. In mouse it resulted in 30% smaller body size than average. Its regular use is
likely to develop cataracts and increases propensity to diabetes. Male mouse tend to experience
gradual loss of testicular functioning. Even human patients who took rapamycin
after transplantation had higher changes of developing diabetes and risked
cataracts. But it still seems to be a promising anti-ageing drug and calibrating
the right doses of medication might tip the balance in favour of longevity with
minimum risks.
Another well studied scientific pathway was related to
dyskeratosis congentia, a condition of telomere dysfunction, wherein rapid shortening
of the telomeres or the ends of chromosomes greatly enhanced ageing. Research
indicated that if cells with the disorder
are rectified then premature ageing can be averted. Thus, offering a great
promise of turning back the clock. Extensive research was done to understand
the role played by telomeres. Carol Gredier, who discovered the enzyme
telomerase and cracked the puzzle of the telomere replenishment, was awarded a
Nobel Prize too.
Scientists of
Harvard Stem Cell Institute hit upon an innovative technique in which a young and an old mice are conjoined
in a Siamese-twin style to share the same blood system but kept everything else separate rejuvenated the older mice. They exhibited new cell growth in their brains,
muscles were stronger and the enlargement of heart which comes with age was
reversed. It was found that a protein GD11 abundant in the younger mice and
scarce in old mice could have turned the tables in favour of anti-ageing.
Further detailed investigations are to be carried out before endorsing the
effects of GD11 scientifically.
In the meanwhile Dena Dubal from the University
of California suggested that increase levels of the hormone klotho causes
mice to live 30% longer. She suggested that nearly 20% of human beings carry
this gene and live on for an extra 3-4 years. These new discoveries added
momentum to the research on longevity. Scientists are hopeful that they can unravel several such strategies that can
interrupt ageing.
Longevity research encompasses the idea of delaying ageing or
facilitating slower ageing. The central focus of the research is staving off
aging. It is not about extending the life indefinitely but prolonging the
healthy life for little longer. No one with a fragile health would want to live
long. After all, the real joy of living
lies in enjoying life to its fullest in the best of physical and mental health.
@ Copyrights reserved.
No comments:
Post a Comment